# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Roth MKM analyst Mike Niehuser maintains Lifezone Metals (NYSE:LZM) with a Buy and maintains $14 price target.
BTIG analyst Gregory Lewis maintains Lifezone Metals (NYSE:LZM) with a Buy and lowers the price target from $14 to $11.
Lifezone Metals granted license in Tanzania, Worthington Steel Inc. reports earnings, Ramaco Resources finds rare earth potenti...
The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...